Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD

NCT00444574 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Methylphenidate Transdermal System
DRUG: Placebo
DRUG: Concerta

Sponsor

Noven Therapeutics